2024-513687-26-00招募中1 期
Anti-GD2 ADC M3554 in Advanced Solid Tumors
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 26
- 试验地点
- 5
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（65+ Years, 18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Global Regulatory Affairs
Scientific
Merck Healthcare KGaA
研究点 (5)
Loading locations...
相似试验
招募中
1 期
Anti-CEACAM5 ADC M9140 in Advanced Solid TumorsAdvanced solid tumors2022-500508-23-00Merck Healthcare KGaA116
招募中
1 期
Study of GS-5319 in Adults With Solid TumorsAdvanced solid tumors2025-522397-36-00Gilead Sciences Inc.35
招募中
1 期
IMA401-101 – Treatment of patients with solid tumors with IMA401 TCER®, a bispecific T-cell receptor (Phase I trial); alone or in combination with checkpoint inhibitorSolid Tumors2023-506854-19-00Immatics Biotechnologies GmbH95
招募中
1 期
BTM-3566 in Advanced Solid TumorsAdvanced Solid TumorsNCT07266285Bantam Pharmaceuticals30
招募中
1 期
A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid TumorsLocally Advanced or Metastatic Malignant Solid TumorsNCT07287995Astellas Pharma Global Development, Inc.428